Home > Services > Cell & Gene Therapy Solution > Immune Cell Therapy Solution > Gene Delivery
Gene Delivery
Lipid nanoparticles (LNPs) and viral vectors are powerful tools for gene delivery with distinct applications. They play pivotal roles in advancing the field of gene delivery, enabling researchers and clinicians to develop innovative genetic medicines with the potential to address unmet medical needs.
LNPs, as non-viral systems, offer remarkable efficiency in delivering nucleic acids, enabling gene editing, rapid vaccine development, and treatment of genetic diseases. Their advatages lie in high encapsulation efficiency, precise manufacturing control, and low toxicity, rendering them suitable for various therapeutic applications.
In contrast, viral vectors utilize modified viruses to deliver genetic material into target cells. They allow precise gene transfer and are commonly used in gene therapy and immunotherapy. Viral vectors have the capability to deliver therapeutic genes to correct genetic defects or modulate cellular functions, thereby presenting potential treatments for a broad spectrum of diseases.
Virus Vector Packaging
AcceGen offers customizable viral vector packaging services, including AAV, lentivirus, adenovirus, and retrovirus packaging. We provide flexibility in using our transfer vectors, custom-designed vectors, or your own vectors. Our catalog also provides a large number of ready-to-use viral vectors for your research applications.
View our Virus Vector Packaging Portfolio
LNPs Delivery System
AcceGen offers reproducible and controlled manufacturing of lipid nanoparticles for efficient gene delivery. With high encapsulation efficiency, tissue penetration and low cytotoxicity, our LNPs enable targeted delivery of nucleic acids in gene editing, vaccine development, immuno-oncology, and rare disease treatment.
View our LNPs Delivery System Portfolio
AcceGen’s gene delivery services encompass lipid nanoparticles (LNPs) and viral vectors, offering versatile solutions for advancing genetic medicine. LNPs provide efficient non-viral delivery of nucleic acids, enabling gene editing and therapy with high encapsulation efficiency, controlled manufacturing, and low toxicity. The viral vector service utilizes viruses to deliver genetic material, facilitating precise gene transfer for gene therapy and immunotherapy applications.
With comprehensive offerings, AcceGen empowers researchers with the tools needed to explore gene delivery, supporting breakthroughs in gene editing, therapy, and the development of novel treatments for genetic disorders.
